Full-Time

Manufacturing Engineer 2

Updated on 9/10/2026

Integer Holdings Corporation

Integer Holdings Corporation

1,001-5,000 employees

Medical device CDMO for cardiac devices

No salary listed

Spiddle West, An Spidéal, Co. Galway, Ireland + 1 more

More locations: Galway, Ireland

In Person

Bachelor's

Category
Manufacturing & Process Engineering (1)
Required Skills
Data Analysis

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Requirements
  • You must have at least a bachelor's degree in an engineering or related technical field and at least three years of relevant experience.
  • Candidates who do not meet the education requirement may be considered with 7+ years of relevant experience.
  • You must be able to work independently and collaboratively with associates and cross-functional teams.
  • You must demonstrate solid technical aptitude and the ability to contribute to a team or produce technical results independently.
  • You must have a functional understanding of Integer Quality Management Systems and be able to complete required Quality System documentation tasks with little or no direction.
  • You must demonstrate competency in written and oral communications.
  • You must maintain a calm demeanor in a high-energy, constantly changing production environment.
Responsibilities
  • You will adhere to Integer's values and all safety, environmental, security, and quality requirements, including Quality Management Systems, Safety, Environmental and Security Management Systems, U.S. Food and Drug Administration regulations, company policies, operating procedures, and other regulatory requirements.
  • You will independently evaluate, select, and apply standard engineering techniques, procedures, and criteria, using judgment to make minor adaptations and modifications to existing specifications, procedures, and work instructions.
  • You will review procedures and plans before implementation and evaluate existing products, processes, and materials for failure analysis and potential improvements.
  • You will investigate, develop, document, and implement new product and process technologies of moderate complexity and scope.
  • You will identify technical challenges, mitigate potential issues, and incorporate improvements.
  • You will plan, schedule, and execute engineering work within a major project or lead a smaller-scope project.
  • You will use standard quality management and production system methodologies to investigate product and process improvement opportunities.
  • You will apply standard data analysis techniques to establish root causes of product and process failures and support improvements.
  • You will observe products and processes, recognize discrepancies, and follow operations through detailed process steps to establish their root causes.
  • You will collaborate with others, exchange information, ask questions, and check for understanding.
  • You will assure adherence to the Quality Management System, facilitate or contribute to corrective and preventive actions, and contribute to quality key performance indicators and the journey to 5 Sigma.
  • You will develop and deploy systems and tools that support innovation and continuous improvement.
  • You will support Manufacturing Excellence through strategy alignment, sustained change, standardization, associate engagement, and systems and process optimization.
  • You will support Environmental Health and Safety programs, achieve site quality key performance indicators, and complete defined goals, objectives, projects, and milestones.
  • You will identify ways to shorten project durations and improve current processes and procedures to increase efficiency.
  • You will generate continuous improvement suggestions and support their implementation.
Desired Qualifications
  • A positive, can-do attitude with a belief that failure is not an option.
Integer Holdings Corporation

Integer Holdings Corporation

View

Integer Holdings Corporation is a large medical device contract development and manufacturing organization (CDMO) that supports medical device makers in cardiac rhythm management, neuromodulation, and cardiovascular markets. It provides end-to-end services from design support to manufacturing, delivering components and finished subsystems such as implants, housings, electrodes, and batteries through its Greatbatch Medical, Lake Region Medical, and Electrochem brands. The company differentiates itself by its scale, breadth of capabilities across multiple medical specialties, established brand portfolio, and global manufacturing footprint that enable reliable, integrated supply. Its goal is to improve patients’ lives worldwide by helping customers bring safe and effective medical technologies to market.

Company Size

1,001-5,000

Company Stage

IPO

Headquarters

Wilmington, Delaware

Founded

1940

Get referred to Integer Holdings Corporation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • KKR will pay $127 cash per share, a 51.8% premium.
  • Q2 2026 adjusted EPS hit $1.60, beating estimates by 15.9%.
  • KKR plans capacity, technology, innovation, and employee ownership investments after closing.

What critics are saying

  • New Ross shut for two unpaid weeks July 27-August 10, signaling demand volatility.
  • Q2 2026 sales fell 2.6% to $464.1 million, with organic sales down 1.5%.
  • Post-deal, Integer delists from NYSE and disappears if approvals or financing break.

What makes Integer Holdings Corporation unique

  • KKR’s August 3, 2026 bid validates Integer’s critical medtech CDMO platform.
  • Integer supplies components for cardiovascular, neuromodulation, and orthopedic devices across major manufacturers.
  • The New Ross facility remains strategically important, with recent capacity and technology investments.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

Disability Insurance

Adoption Assistance

Parental Leave

401(k) Company Match

401(k) Retirement Plan

Paid Vacation

Paid Holidays

Company News

Ticker Report
Aug 29th, 2026
Boussard & Gavaudan Gestion Sas Makes New $2.60 Million Investment in Integer Holdings Corporation $ITGR

Boussard & Gavaudan Gestion Sas bought a new position in Integer Holdings Corporation (NYSE:ITGR – Free Report) during the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 28,153 shares of the medical equipment provider’s stock, valued at approximately $2,597,000. Other institutional investors and hedge funds also […]

Yahoo Finance
Aug 16th, 2026
Healthcare stocks outpace S&P 500 by 13 percentage points over six months

Healthcare stocks have returned 26.1% over the past six months, outperforming the S&P 500 by 13.1 percentage points. However, investors must remain cautious due to heavy regulation affecting earnings potential. Integer Holdings faces concerns with 6.1% annual revenue growth over two years, lagging healthcare peers. Its modest revenue base of $1.84 billion provides less fixed cost leverage than larger competitors. The company trades at $125.07 per share, or 18.6 times forward price-to-earnings. Evolent Health shows weak platform performance and declining returns on capital. Its high net-debt-to-EBITDA ratio of 7 times could force unfavourable capital raises if market conditions worsen. Shares trade at $4.15, representing 12.4 times forward price-to-earnings. Tenet Healthcare, operating hospitals and surgical centres across nine US states, emerges as the recommended healthcare investment.

Yahoo Finance
Aug 4th, 2026
Integer Holdings acquired by KKR for $5.7B in all-cash deal at $127 per share

Integer Holdings agreed to be acquired by private equity firm KKR in an all-cash deal valued at approximately $5.7 billion. The transaction values the medical technology company at $127 per share. Shares jumped 2.7% in afternoon trading, continuing a rally from the previous session when the stock surged over 20% following the announcement. The acquisition news overshadowed strong second-quarter results, where Integer posted an adjusted profit of $1.60 per share on $464.1 million in revenue, surpassing analyst estimates. Following the buyout announcement, Integer withdrew its previously issued financial guidance and cancelled its upcoming earnings conference call. Shares traded at $124.50, marking a new 52-week high.

BizWire Express
Aug 3rd, 2026
KKR to acquire Integer for $5.7B in all-cash deal at $127 per share

KKR has agreed to acquire Integer Holdings Corporation, a medical device contract development and manufacturing organisation, in an all-cash transaction valued at approximately $5.7 billion. Integer stockholders will receive $127 per share, representing a 51.8% premium to the company's closing share price on 29 April 2026. The acquisition follows a comprehensive strategic review announced by Integer in April 2026. The Integer Board unanimously approved the agreement and recommends stockholder approval. KKR plans to invest in Integer's capacity, technology, innovation, and talent. The firm also intends to establish a broad-based employee ownership programme following the transaction's close, consistent with its approach across portfolio companies. The transaction is expected to close by year-end, subject to stockholder approval and regulatory clearances. Upon completion, Integer will become privately held and delist from the New York Stock Exchange.

Yahoo Finance
Aug 3rd, 2026
Integer Holdings beats Q2 expectations with $464M revenue and $1.60 earnings per share

Integer Holdings Corp. reported second-quarter net income of $23.6 million, or 69 cents per share. Adjusted earnings came to $1.60 per share, exceeding Wall Street expectations of $1.38 per share. The Plano, Texas-based medical device outsource manufacturer posted revenue of $464.1 million for the period, also beating analyst forecasts of $452.5 million. The results surpassed predictions from five analysts surveyed by Zacks Investment Research on both earnings and revenue metrics.